1.
Chinese Journal of Endocrinology and Metabolism
;
(12): 451-453, 2011.
Artigo
em Chinês
| WPRIM
| ID: wpr-416922
RESUMO
The epidemic characteristics of differentiated thyroid cancer(DTC)are changing, thyrotropin(TSH)suppressive therapy is also improving in recent years. The risks of recurrence and the death of patients, as well as the adverse effects of levothyroxine sodium treatment should be fully considered during thyroid hormone administration for patients of DTC. Hence, the degree of TSH suppression should be individualized in patients with DTC.